NCT04836429View on ClinicalTrials.gov

Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 10, 2022

Primary Completion Date

February 3, 2024

Study Completion Date

January 3, 2026

Conditions
Lung Non-Small Cell CarcinomaPleural Disorder
Interventions
DRUG

Porfimer Sodium

Given IV

PROCEDURE

Video-Assisted Thoracic Surgery

Undergo VATS

DRUG

Photodynamic Therapy

Undergo photodynamic therapy

DEVICE

Intraoperative PDT

Subjects will receive one course of light therapy at the time of surgery

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER